Potential of VEGFR2 expression as a predictive marker of PD-1 blockade in patients with advanced NSCLC

Angiogenesis serves a crucial role in cancer progression. Vascular endothelial growth factor (VEGF) exhibits an immunosuppressive function in patients with cancer. However, it remains unclear whether expression of VEGF in tumor tissue can predict the outcome of programmed death-1 blockade in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaira, Kyoichi, Imai, Hisao, Kawasaki, Tomonori, Hashimoto, Kousuke, Miura, Yu, Shiono, Ayako, Yamaguchi, Ou, Mouri, Atsuto, Kobayashi, Kunihiko, Yasuda, Masanori, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641704/
https://www.ncbi.nlm.nih.gov/pubmed/36281948
http://dx.doi.org/10.3892/or.2022.8429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641704/
https://www.ncbi.nlm.nih.gov/pubmed/36281948
http://dx.doi.org/10.3892/or.2022.8429

Ejemplares similares